Please login to the form below

Not currently logged in
Email:
Password:

crenezumab

This page shows the latest crenezumab news and features for those working in and with pharma, biotech and healthcare.

Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms

Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms

The failure of two other beta amyloid targeting agents this year – AC Immune and Roche’s crenezumab and Eisai and Biogen’s aducanumab has lead many to declare the need to

Latest news

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics